...
首页> 外文期刊>Applied Microbiology and Biotechnology >Marine actinobacteria associated with marine organisms and their potentials in producing pharmaceutical natural products
【24h】

Marine actinobacteria associated with marine organisms and their potentials in producing pharmaceutical natural products

机译:与海洋生物有关的海洋放线菌及其在生产天然药物中的潜力

获取原文
获取原文并翻译 | 示例
           

摘要

Actinobacteria are ubiquitous in the marine environment, playing an important ecological role in the recycling of refractory biomaterials and producing novel natural products with pharmic applications. Actinobacteria have been detected or isolated from the marine creatures such as sponges, corals, mollusks, ascidians, seaweeds, and seagrass. Marine organism-associated actinobacterial 16S rRNA gene sequences, i.e., 3,003 sequences, deposited in the NCBI database clearly revealed enormous numbers of actinobacteria associated with marine organisms. For example, RDP classification of these sequences showed that 112 and 62 actinobacterial genera were associated with the sponges and corals, respectively. In most cases, it is expected that these actinobacteria protect the host against pathogens by producing bioactive compounds. Natural products investigation and functional gene screening of the actinobacteria associated with the marine organisms revealed that they can synthesize numerous natural products including polyketides, isoprenoids, phenazines, peptides, indolocarbazoles, sterols, and others. These compounds showed anticancer, antimicrobial, antiparasitic, neurological, antioxidant, and anti-HIV activities. Therefore, marine organism-associated actinobacteria represent an important resource for marine drugs. It is an upcoming field of research to search for novel actinobacteria and pharmaceutical natural products from actinobacteria associated with the marine organisms. In this review, we attempt to summarize the present knowledge on the diversity and natural products production of actinobacteria associated with the marine organisms, based on the publications from 1991 to 2013.
机译:放线菌在海洋环境中无处不在,在耐火生物材料的循环利用和生产具有制药用途的新型天然产物方面起着重要的生态作用。放线菌已从海绵,珊瑚,软体动物,海生动物,海藻和海草等海洋生物中检出或分离出来。与海洋生物相关的放线菌的16S rRNA基因序列(即3,003个序列)存储在NCBI数据库中,清楚地揭示了与海洋生物相关的大量放线菌。例如,这些序列的RDP分类显示​​112和62个放线菌属分别与海绵和珊瑚有关。在大多数情况下,期望这些放线菌通过产生生物活性化合物来保护宿主免受病原体的侵害。天然产物的研究和与海洋生物有关的放线菌的功能基因筛选显示,它们可以合成许多天然产物,包括聚酮化合物,类异戊二烯,吩嗪,肽,吲哚并咔唑,固醇等。这些化合物显示出抗癌,抗微生物,抗寄生虫,神经,抗氧化剂和抗HIV活性。因此,海洋生物相关的放线菌代表了海洋药物的重要资源。从与海洋生物有关的放线菌中寻找新的放线菌和天然药物,这是一个即将到来的研究领域。在本综述中,我们尝试根据1991年至2013年的出版物,总结与海洋生物相关的放线菌多样性和天然产物生产的现有知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号